Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice

September 2024 | New Publication
Wu G et al., J Clin Invest. 2024
This study showcases the potential of AAV as a gene delivery platform for challenging cell types. The development of AAV2-GEC and its successful application in the treatment of antibody-mediated kidney disease represents a significant step forward and opens up promising avenues for kidney medicine.
 
 1st_pic_Adeno-associated_virus-based_gene_therapy_treats_inflammatory_kidney_disease_in_mice.jpeg
 

For further information visit: 
JCI - Adeno-associated virus-based gene therapy treats inflammatory kidney disease in mice

Back to News & Career

More articles in this category

Martinistraße 52
Campus Research N27
20246 Hamburg Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

Calculate route

Categories

Services

University Medical Center Hamburg - Eppendorf

III. Department of Medicine